Lion Biotechnologies Inc (LBIO)

7.95
0.05 0.62
NASDAQ : Health Care
Prev Close 8.00
Open 8.05
Day Low/High 7.70 / 8.05
52 Wk Low/High 4.45 / 8.60
Volume 347.20K
Avg Volume 427.00K
Exchange NASDAQ
Shares Outstanding 62.35M
Market Cap 433.34M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

'Sell the News' Reaction Is Quite Logical

After poor close on Thursday, market trends down all day.

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

Biotech Stock Mailbag: Bristol, Exelixis, Lion Bio, GW Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Sneaky Market Strength Has Nothing to Do With the Fed

Anxiety over being left behind is building.

Yawning All the Way to the Fed Decision

We have a few more days of this slow trading, and it is unlikely to change much.

RSI Alert: Lion Biotechnologies (LBIO) Now Oversold

RSI Alert: Lion Biotechnologies (LBIO) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Health Care Stocks Under $10 Set to Soar

5 Health Care Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

Market's Not in the Mood to Move

Attention turns to earnings and away from Greece, Fed.

Strong Finish Is Key for Market

But there's still the problem of limited upside momentum.

Bit of a Bounce Brings Sigh of Relief

Uncertainty on Greece prevails, but it could have been worse.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer sees a week bookended by Greece and the monthly jobs report, with many company earnings for good measure.

First Week of August 21st Options Trading For Lion Biotechnologies (LBIO)

First Week of August 21st Options Trading For Lion Biotechnologies (LBIO)

Investors in Lion Biotechnologies Inc saw new options become available this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LBIO options chain for the new August 21st contracts and identified the following put contract of particular interest.

Lion Biotechnologies Becomes Oversold (LBIO)

Lion Biotechnologies Becomes Oversold (LBIO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

So Much for the Fed as Market Catalyst

There's still good support, but tight range remains.

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

Stock Index Tracking Red-Hot Cancer Immunotherapy Field Launched

The Loncar Cancer Immunotherapy Index (LCINDX) tracks biopharma companies developing (or already marketing) drugs which use the body's own immune system to target and kill cancer cells.

No Quit in This Market

Much of the trading was driven by computers and index buying.

Players Are Waiting for ... Something

Market can't make up its mind in short week.

S&P Finally Has 2 Good Days in a Row

But window dressing is the theme of the day.

There's Action Below the Surface

Biotechs are still bubbly in 'stock pickers' market.